Welcome to our dedicated page for Oxford Square Ca SEC filings (Ticker: OXSQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oxford Square Capital Corp. filings document regulatory disclosures for a closed-end, non-diversified management investment company focused on corporate debt securities and CLO structured finance investments. Form 8-K reports furnish quarterly and fiscal-year results, including net asset value, net investment income and press-release exhibits, and report material events such as amendments to equity distribution arrangements under an effective Form N-2 shelf registration statement.
The filing record also covers capital structure and governance matters, including Nasdaq-listed common stock, 5.50% Notes due 2028, 7.75% Notes due 2030, charter amendments affecting authorized capital stock, and Form 25 delisting and registration-withdrawal records for a prior notes class.
Oxford Square Capital Corp. President and COO Saul B. Rosenthal bought shares of the company in the open market. On May 20, 2026, he purchased 144,703 shares of common stock at a weighted average price of $1.1517 per share in an open-market transaction.
The purchased shares were acquired into a joint tenants in common account in which Rosenthal has a 50% pecuniary interest, with CEO Jonathan H. Cohen holding the other 50%. After this transaction, Rosenthal directly owned 2,201,479 common shares and indirectly held 1,898 shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. Chief Executive Officer Jonathan H. Cohen reported an open-market purchase of 144,704 shares of common stock at a weighted average price of $1.1517 per share on May 20, 2026. The shares were bought into a joint tenants in common account in which Cohen has a 50% pecuniary interest and President and COO Saul B. Rosenthal holds the other 50%. Following this transaction, Cohen directly owns 2,417,193 common shares and indirectly holds 1,898 additional shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. amended its charter to expand its flexibility to issue stock in the future. The company increased its total authorized capital stock from 100,000,000 shares to 300,000,000 shares, all designated as common stock with a par value of $0.01 per share. The Articles of Amendment were filed with the Maryland State Department of Assessments and Taxation and became effective immediately upon filing.
Oxford Square Capital Corp. filed an 8-K describing amendment no. 1 to its amended and restated equity distribution agreement with Oxford Square Management, Oxford Funds, Lucid Capital Markets and Ladenburg Thalmann as sales agents. The amendment allows sales of common stock to continue under the company’s effective Form N-2 shelf registration statement, supported by a new prospectus supplement dated May 5, 2026.
The company also filed a legality opinion from Dechert LLP covering shares to be sold pursuant to the amended equity distribution agreement, together with related consent and technical XBRL exhibit items.
Oxford Square Capital Corp. filed a prospectus supplement to offer up to $150,000,000 of common stock under an amended "at-the-market" equity distribution agreement with Lucid Capital Markets and Ladenburg Thalmann. The program permits sales from time to time, with sales agents paid the lesser of 2.0% or the spread to NAV. As of April 30, 2026, 93,527,087 shares were outstanding and the company reported a net asset value of $1.32 per share as of March 31, 2026. From August 1, 2019 to April 30, 2026, the company sold 37,794,797 shares under its prior ATM program, raising approximately $96.0 million in gross proceeds (net proceeds ~$94.1 million). Proceeds from any sales will be used to fund investments aligned with the BDC’s strategy or held temporarily in high-quality short-term investments. The offering may result in dilution and shares can trade at discounts to NAV.
Oxford Square Capital Corp. reports weaker Q1 2026 results, with net assets falling to $123.3 million from $145.4 million at year-end 2025 and net asset value per share declining from $1.69 to $1.32. Total assets were $278.9 million, including $235.4 million of investments at fair value and $40.6 million in cash equivalents.
The company generated net investment income of $4.15 million, or $0.05 per share, but realized losses of $30.7 million and modest unrealized gains of $1.1 million drove a net decrease in net assets from operations of $25.5 million, or $(0.29) per share. Distributions totaled $0.105 per share for the quarter.
The portfolio remains heavily invested in senior secured loans and CLO equity. CLO equity fair value declined to about $72.2 million, and aggregate net unrealized depreciation on investments reached roughly $147.7 million versus tax cost. Operating cash flow was negative at $14.4 million, while common stock issuance provided $12.3 million of new equity. Qualifying assets represented 74.5% of total assets, above the BDC regulatory threshold.
Oxford Square Capital Corp. reported first quarter 2026 results and declared monthly common stock distributions of $0.035 per share for July, August, and September 2026. These payments have record dates of July 17, August 17, and September 16, 2026, respectively.
For the quarter ended March 31, 2026, the company generated total investment income of $8.9 million and net investment income of $4.1 million, or $0.05 per share. Large realized losses on investments of $30.7 million, partially offset by $1.1 million of unrealized gains, led to a net decrease in net assets from operations of $25.5 million, or $0.29 per share.
Net asset value per share fell from $1.69 at December 31, 2025 to $1.32 at March 31, 2026, and total return based on NAV was (15.68)% for the quarter. Total assets were $278.9 million and net assets were $123.3 million as of March 31, 2026.
Oxford Square Capital Corp. filed a shelf registration on Form N-2 to offer up to $300,000,000 of securities. The shelf permits one or more offerings of common stock, preferred stock, debt securities, subscription rights and warrants, with terms to be set in prospectus supplements.
The company is a closed-end BDC focused on below-investment-grade corporate debt and CLO equity; on April 14, 2026 its common stock last traded at $1.91 and its reported net asset value was $1.69 per share as of December 31, 2025. The prospectus discloses an existing $150.0 million ATM program (up to $150.0 million) under which the company raised approximately $96.0 million (net proceeds ~$94.1 million) from 37,794,797 shares sold through April 8, 2026.
Oxford Square Capital Corp. is a Maryland-based business development company that invests mainly in senior secured corporate loans and collateralized loan obligation (CLO) equity to maximize total return. It operates as a regulated investment company for U.S. federal tax purposes and must keep at least 70% of assets in qualifying investments.
In 2025 the company redeemed all $44.8 million of its 6.25% unsecured notes due 2026 and had $80.5 million of 5.50% unsecured notes due 2028 and $74.8 million of 7.75% unsecured notes due 2030 outstanding. It also raised approximately $34.8 million of net capital by selling 15,910,780 common shares through an at-the-market program.
During the year ended December 31, 2025, Oxford Square purchased approximately $92.1 million of new investments and, by fair value, its portfolio was 58.5% in senior secured notes, 37.8% in CLO equity, and 3.7% in equity and other holdings. The ten largest positions represented 48.3% of portfolio fair value and are concentrated in structured finance, business services, software, telecommunications and industrials.